Evista, the established osteoporosis drug, is no new in the market shelves. Though, the internists and gynecologists are for long familiar with the old drug, it is a brand new one for the chemotherapists. Yes, the osteoporosis-treating drug,...

A major government study has found that the osteoporosis drug Evista works as well as tamoxifen in reducing breast cancer risk. It has fewer serious side effects than tamoxifen. The study included nearly 20,000 post-menopausal women of the average...